Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Troiano
The Addition at Day 9 of Hd-MTX to the (Da)-Epoch Scheme With or Without Rituximab Is an Effective Regimen in Untreated Advanced Stage High Risk Lymphoma: A Feasibility Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Immunochemotherapy With Obinutuzumab or Rituximab in Previously Untreated Follicular Lymphoma in the Randomised Phase Iii Gallium Study: Analysis by Chemotherapy Regimen
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
High-Dose Methotrexate With or Without Rituximab in Newly Diagnosed Primary CNS Lymphoma
Neurology
Neurology
T(11;18)(q21;q21)-Positive Advanced-Stage MALT Lymphoma Associated With Monoclonal Gammopathy : Resistance to Rituximab or Rituximab-Containing Chemotherapy
Journal of clinical and experimental hematopathology : JCEH
Medicine
Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Rituximab Plus Lenalidomide Is as Effective as Immunochemotherapy in the Eradication of Molecular Disease in Untreated Follicular Lymphoma: Relevance Lysa Ancillary Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Da-Epoch-R Versus R-Chop in High Risk DLBCL Patients: Analysis of the Czech Lymphoma Study Group (Clsg)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Differences in Quality of Life Between Bendamustine-Rituximab and R-Chop/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Correction To: White Matter Changes in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate With or Without Rituximab
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
The Glasgow Prognostic Score at Diagnosis Is an Independent Predictor of Survival in Advanced Stage Classical Hodgkin Lymphoma
British Journal of Haematology
Hematology
